Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jessen

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Design, synthesis and ribosome binding of chloramphenicol nucleotide and intercalator conjugatesDorte Johansson, Carsten H Jessen, Jacob Pøhlsgaard, et al.
Family Practice|April 27, 2021
Cancer suspicion, referral to cancer patient pathway and primary care interval: a survey and register study exploring 10 different types of abdominal cancerNanna H Jessen, Henry Jensen, Charles W Helsper, et al.
Scientific Reports|October 18, 2017
Incomplete Ionization of a 110 meV Unintentional Donor in β-Ga<sub>2</sub>O<sub>3</sub> and its Effect on Power DevicesAdam T Neal, Shin Mou, Roberto Lopez, et al.
The Journal of Infectious Diseases|November 24, 1999
Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoirF Lori, H Jessen, J Lieberman, et al.
Journal of Viral Hepatitis|February 22, 2005
Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven casesM Vogel, B Bieniek, H Jessen, et al.
European Journal of Medical Research|September 3, 2002
Predictors of treatment failure during highly active antiretroviral therapy (racing trial)A Masuhr, M Mueller, V Simon, et al.
The Open AIDS Journal|June 7, 2011
A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN TrialK U Ulbricht, G M Behrens, M Stoll, et al.
Respiratory Research|July 15, 2021
Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosisH Jessen, N Hoyer, T S Prior, et al.
Nucleosides, Nucleotides & Nucleic Acids|March 27, 2004
Intercalating nucleic acids: the influence of linker length and intercalator type on their duplex stabilitiesUlf B Christensen, Michael Wamberg, Farag A G El-Essawy, et al.
AIDS Research and Human Retroviruses|November 14, 1997
Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistanceF Lori, A G Malykh, A Foli, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Design, synthesis and ribosome binding of chloramphenicol nucleotide and intercalator conjugatesDorte Johansson, Carsten H Jessen, Jacob Pøhlsgaard, et al.
Family Practice|April 27, 2021
Cancer suspicion, referral to cancer patient pathway and primary care interval: a survey and register study exploring 10 different types of abdominal cancerNanna H Jessen, Henry Jensen, Charles W Helsper, et al.
Scientific Reports|October 18, 2017
Incomplete Ionization of a 110 meV Unintentional Donor in β-Ga<sub>2</sub>O<sub>3</sub> and its Effect on Power DevicesAdam T Neal, Shin Mou, Roberto Lopez, et al.
The Journal of Infectious Diseases|November 24, 1999
Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoirF Lori, H Jessen, J Lieberman, et al.
Journal of Viral Hepatitis|February 22, 2005
Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven casesM Vogel, B Bieniek, H Jessen, et al.
European Journal of Medical Research|September 3, 2002
Predictors of treatment failure during highly active antiretroviral therapy (racing trial)A Masuhr, M Mueller, V Simon, et al.
The Open AIDS Journal|June 7, 2011
A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN TrialK U Ulbricht, G M Behrens, M Stoll, et al.
Respiratory Research|July 15, 2021
Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosisH Jessen, N Hoyer, T S Prior, et al.
Nucleosides, Nucleotides & Nucleic Acids|March 27, 2004
Intercalating nucleic acids: the influence of linker length and intercalator type on their duplex stabilitiesUlf B Christensen, Michael Wamberg, Farag A G El-Essawy, et al.
AIDS Research and Human Retroviruses|November 14, 1997
Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistanceF Lori, A G Malykh, A Foli, et al.
Pageof 6